Monamine oxidase inhibitors and brain monamines in clinical conditions.
作者信息
Pare C M
出版信息
Biochem J. 1971 Feb;121(3):36P-37P. doi: 10.1042/bj1210036p.
Abstract
摘要
相似文献
1
Monamine oxidase inhibitors and brain monamines in clinical conditions.临床情况下的单胺氧化酶抑制剂与脑单胺
Biochem J. 1971 Feb;121(3):36P-37P. doi: 10.1042/bj1210036p.
2
[Effect of dihydroxyphenylalanine on the serotonin content of rat brain following pretreatment with monoamine oxidase inhibitors].
Acta Biol Med Ger. 1966;17(5):637-43.
3
The serotonin-catecholamine-dream bicycle: a clinical study.
Biol Psychiatry. 1972 Aug;5(1):33-64.
4
Effects of 1-(indolyl-2-carbonyl)-2-alkyl-hydrazine derivatives on amine levels and monoamine oxidase activity in rat tissues.
Biochem Pharmacol. 1972 Oct 1;21(19):2571-5. doi: 10.1016/0006-2952(72)90225-0.
5
Monoamines and mental disease.单胺类与精神疾病。
Proc R Soc Med. 1972 Jul;65(7):584-5. doi: 10.1177/003591577206500702.
6
Mood and sleep changes with monoamine-oxidase inhibitors.单胺氧化酶抑制剂引起的情绪和睡眠变化。
Proc R Soc Med. 1973 Sep;66(9):951. doi: 10.1177/003591577306600962.
7
The effects of perturbation of cerebral amine metabolism on operationally defined learning and memory processes of goldfish.
Biol Psychiatry. 1974 Dec;9(3):295-323.
8
Selective increase of brain dopamine induced by gamma-hydroxybutyrate: study of the mechanism of action.γ-羟基丁酸诱导的脑多巴胺选择性增加：作用机制研究
J Neurochem. 1968 May;15(5):377-81. doi: 10.1111/j.1471-4159.1968.tb11624.x.
9
[Recent views on the biochemical aspects of the mode of action of analgesics acting like morphine in the central nervous system].[关于在中枢神经系统中作用类似吗啡的镇痛药作用方式的生化方面的最新观点]
Klin Wochenschr. 1972 Apr 15;50(8):401-9. doi: 10.1007/BF01497566.
10
Clinical implications of monoamine oxidase inhibition.
Adv Biochem Psychopharmacol. 1972;5:441-4.
本文引用的文献
1
Changes in the 5-hydroxytryptamine content of rat, rabbit and human brain after death.大鼠、兔和人死后大脑中5-羟色胺含量的变化。
Br J Pharmacol Chemother. 1962 Apr;18(2):370-80. doi: 10.1111/j.1476-5381.1962.tb01417.x.
2
EFFECT OF MONOAMINE-OXIDASE INHIBITORS ON THE CONCENTRATIONS OF 5-HYDROXYTRYPTAMINE IN THE HUMAN BRAIN.单胺氧化酶抑制剂对人脑中5-羟色胺浓度的影响。
Lancet. 1965 Jul 31;2(7405):205-8. doi: 10.1016/s0140-6736(65)90693-8.
3
POTENTIATION OF MONOAMINE-OXIDASE INHIBITORS BY TRYPTOPHAN.色氨酸对单胺氧化酶抑制剂的增效作用
Lancet. 1963 Sep 7;2(7306):527-8. doi: 10.1016/s0140-6736(63)90271-x.
4
Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan.色氨酸对单胺氧化酶抑制剂抗抑郁作用的增强效应。
Lancet. 1963 Jan 12;1(7272):79-81. doi: 10.1016/s0140-6736(63)91084-5.
5
Differentiation of two genetically specific types of depression by the response to anti-depressants.通过对抗抑郁药的反应来区分两种基因特异性抑郁症类型。
Lancet. 1962 Dec 29;2(7270):1340-3. doi: 10.1016/s0140-6736(62)91019-x.
6
5-Hydroxytryptamine in the hind-brain of depressive suicides.抑郁自杀者后脑内的5-羟色胺
Br J Psychiatry. 1967 Dec;113(505):1407-11. doi: 10.1192/bjp.113.505.1407.
7
The effects of psychoactive drugs on norepinephrine-3-H metabolism in brain.精神活性药物对大脑中去甲肾上腺素-3-H代谢的影响。
Biochem Pharmacol. 1967 Feb;16(2):393-9. doi: 10.1016/0006-2952(67)90040-8.
8
Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania.精神抑郁和躁狂时脑脊液中的酸性单胺代谢产物。
J Neurochem. 1966 Dec;13(12):1545-8. doi: 10.1111/j.1471-4159.1966.tb04320.x.
9
Differentiation of two genetically specific types of depression by the response to antidepressant drugs.
Humangenetik. 1970;9(3):199-201. doi: 10.1007/BF00279212.
10
Mental symptoms in Parkinsonian patients treated with L-dopa.
Lancet. 1970 Jul 25;2(7665):177-9. doi: 10.1016/s0140-6736(70)92535-3.
Zotero 插件